By Cynthia Kim and Hyunjoo Jin SEOUL, July 7 (Reuters) - U.S. chip design giant Synopsys plans to stop offering a suite of ...
Synopsys shifts resources away from manufacturing softwareSynopsys (NASDAQ:SNPS) is preparing to discontinue a suite of ...
Synopsys plans to stop offering manufacturing process control software. This move allows the company to divert resources to ...
Synopsys plans to discontinue its manufacturing process control software, reallocating resources to high-margin AI design ...
Vertex Pharmaceuticals (VRTX +0.27%) is acquiring Crinetics Pharmaceuticals (CRNX 0.47%) for $10 billion, expanding beyond ...
Clinical Program Advances Following Favorable Safety Review; Peer-Reviewed Publication Further Validates Deciparticle™ Platform ...
Shares of Ondas Inc. ONDS jumped 5.5% yesterday after the company announced the acquisition of DZYNE Technologies, a deal ...
Synopsys is reportedly ending its fab manufacturing control software to redirect engineers towards higher-margin AI chip design, sources tell Reuters.
The software won an R&D 100 Award in 2023. Researchers have had conversations with about 120 potential customers to guide ...
Mastercam, the world's leading CAD/CAM software provider and part of the Sandvik Group, today announced the successful ...
Investment will help firm expand into US and UK markets ...
The entrepreneur proposed ready-to-use factory units equipped with electricity, regulatory approvals, shared machinery and ...